BioSpace News Archive

Business

Epsilogen announces significant expansion of management team with three new senior hires

Epsilogen Ltd, a global leader in the development of novel immunoglobulin E antibodies to treat cancer, announced three new senior hires in what is a significant expansion of their management team.

April 26, 2023

·

3 min read

Business

Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal

Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announced that it has added the Instituto de Microecologia in Madrid to its growing network of lab partners across Europe and in select international markets.

April 26, 2023

·

6 min read

Stallergenes Greer Foundation to Foster Innovation and Precision Medicine in the Field of Allergy

Stallergenes Greer, a biopharmaceutical company specialising in the research, diagnosis and treatment of respiratory allergies, is pleased to announce its strategic direction for the Stallergenes Greer Foundation.

April 26, 2023

·

3 min read

Business

Leaders in Breast and Lung Cancer treatment join SystImmune Inc’s Clinical Science Advisory Committee

SystImmune Inc. has announced the creation of its Clinical Science Advisory Committee, appointing Dr. Hope Rugo, M.D., Dr. Sara Tolaney, M.D., M.P.H, Dr. Pasi Jänne, M.D., Ph.D., MMSC.

April 26, 2023

·

7 min read

Pharm Country

Immunic to Participate in Investor and Scientific Conferences in May 2023

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced participation in the following investor and scientific conferences in May.

April 26, 2023

·

7 min read

Business

Boston Scientific Announces Results for First Quarter 2023

Boston Scientific Corporation generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported basis, 14.9 percent on an operational1 basis and 14.0 percent on an organic2 basis, all compared to the prior year period.

April 26, 2023

·

20 min read

Business

Oxford Biomedica Appoints Leone Patterson as Non-Executive Director

Oxford Biomedica plc (LSE:OXB) today announces the appointment of Ms Leone Patterson as an Independent Non-Executive Director.

April 26, 2023

·

3 min read

Business

Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing

Genenta Science S.p.A. today announced its fiscal year 2022 financial results and that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2022 (the “Annual Report”) with the Securities and Exchange Commission (“SEC”).

April 26, 2023

·

4 min read

Pharm Country

Rumi Scientific Announces Data Demonstrating Disease Modifying Effect of BRD9 Inhibition in a Huntington’s Disease Animal Model

Rumi Scientific announced data demonstrating in vivo proof of concept of a disease modifying effect of bromodomain protein 9 (BRD9) inhibition as a potential treatment for Huntington’s disease (HD).

April 26, 2023

·

3 min read

Mindset Pharma Files Two Patent Applications for its Non-Hallucinogenic Non-Tryptamine Compounds

Mindset Pharma Inc. today announced that it has filed two international patent applications under the Patent Coorperation Treaty (“PCT”) for the protection of certain of Mindset’s non-hallucinogenic novel non-tryptamine compounds known as “Family 6.”

April 26, 2023

·

4 min read